Medical News

RSS

Amorfix Life Sciences detects AD-associated aggregated Beta-amyloid in blood plasma

Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases such as Alzheimer's disease (AD), announced today the detection of the AD-associated aggregated Beta-amyloid (ABeta), the hallmark of AD, in the blood from the most-frequently-used animal model of AD. The assay detects both oligomeric and fibrillar aggregates of ABeta, which are generally considered to be the toxic forms and major contributors to brain dysfunction in AD.

4 May 2010

Mylan Pharmaceuticals receives FDA approval for Bupropion HCl ER Tablets

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Bupropion Hydrochloride Extended-release Tablets USP, 150 mg, the generic version of GlaxoSmithKline's smoking cessation aid, Zyban.

4 May 2010

Chances of surviving lung cancer much lower in England than in Norway or Sweden: Scientists

The chances of surviving lung cancer are much lower in England than they are in Norway or Sweden, scientists at King's College London have found.

4 May 2010

Henry Schein's net sales for first-quarter 2010 increase 18.5% to $1.8 billion

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended March 27, 2010.

4 May 2010

Tenet Healthcare reports adjusted EBITDA of $298 million for first-quarter 2010

Tenet Healthcare Corporation today reported adjusted EBITDA of $298 million for the quarter ended March 31, 2010, an increase of $20 million, or 7.2 percent, as compared to $278 million for the first quarter of 2009. Net income attributable to common shareholders for the first quarter of 2010 was $88 million, or $0.17 per diluted share, compared to $44 million, or $0.09 per diluted share, excluding a gain of $134 million, or $0.28 per diluted share, in the first quarter of 2009 related to the early extinguishment of debt.

4 May 2010

GTx reports net income of $44.3M for first-quarter 2010 compared with net loss of $11.3M in 2009

GTx, Inc. today reported financial results for the first quarter of 2010. The net income for the first quarter ended March 31, 2010 was $44.3 million compared with a net loss of $11.3 million for the same period in 2009. Net income for the current period included the recognition of approximately $54.9 million in collaboration revenue due to the termination of our license and collaboration agreement with Merck & Co., Inc in March 2010.

4 May 2010

First Edition: May 4, 2010

Today's headlines include stories about parts of the new health reform law dealing with long-term care, high risk insurance pools and early retiree health insurance.

4 May 2010

Celsion reports $4.6 million net loss from operations for first-quarter 2010

Celsion Corporation, a leading oncology drug development company, announced today financial results for the first quarter ended March 31, 2010 and addressed the progression of the clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin. ThermoDox® is currently being evaluated in the Phase III HEAT trial for the treatment of hepatocellular carcinoma (HCC) and in a Phase I/II trial for patients with recurrent chest wall breast cancer.

4 May 2010

Positive results from Phase 2 clinical trial of TAKSTA in patients with ABSSSI

Cempra Pharmaceuticals today announced positive results from its Phase 2 clinical trial evaluating the efficacy and tolerability of the novel front loading dosing regimen of TAKSTA (CEM-102, sodium fusidate), the company's oral, anti-methicillin-resistant Staphylococcus aureus antibiotic.

4 May 2010

Personalized vaccine processed using tumor tissue promising for brain tumor treatment

Each day in the United States, 482 people are diagnosed with a brain tumor. For these 482 people, not many treatments exist. With the current treatments available, only 5% of those diagnosed with a Glioblastoma Multiform will survive more than 5 years. Only two new treatments have been approved by the FDA in the past two decades.

4 May 2010

New study finds stereotypies in more than 60% of orphaned or abandoned children

Stereotypies -- repetitive behaviors such as rocking, flapping, spinning objects and head-banging – are commonly seen in people with autism or mental retardation. They can also be acquired by children exposed to severe neglect and deprivation, along with declines in IQ, mental health and language.

4 May 2010

Pay-for-performance programs could end up widening medical disparities: RAND study

Rewarding primary care physicians for providing better care to patients could end up widening medical disparities experienced by poorer people and those belonging to racial and ethnic minorities, according to a new RAND Corporation study.

4 May 2010

Cardiovascular specialists demonstrate effectiveness of using stents to repair aortas

A UC Davis team of cardiovascular specialists has demonstrated the effectiveness of using stents -- as compared to traditional open-chest surgery -- to repair aortas that are torn as the result of accidents. The researchers will present their findings at the American Association for Thoracic Surgery Aortic Symposium 2010, which takes place April 29-30 in New York City.

4 May 2010

Phase 2 clinical trial data of voreloxin to be presented at 2010 ASCO Annual Meeting: MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Sunesis Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

4 May 2010

Karolinska Institutet researchers discover new control mechanism in immune system

Researchers at the Swedish medical university Karolinska Institutet have discovered a new control mechanism in our immune system. The discovery is of potential significance to the treatment of serious diseases such as MS (multiple sclerosis), rheumatoid arthritis, and SLE (Systemic lupus erythematosus).

4 May 2010

MicroStockProfit.com releases Hansen Medical investment report

MicroStockProfit.com announces an investment report featuring Hansen Medical Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

4 May 2010

Pilot pneumonia-prevention program reduces postoperative pneumonia in hospital surgical ward: Research

The results of new research results published in the April issue of the Journal of the American College of Surgeons show that a pilot pneumonia-prevention program significantly reduced postoperative pneumonia in a hospital surgical ward.

4 May 2010

Approval of personalized therapy for lung cancer in Europe will change way of treatment

The recent approval of Europe's first personalized treatment for lung cancer heralds the arrival of a new era for lung cancer treatment that will demand significant changes to the way cancer specialists and other hospital doctors work, a leading expert said today at the 2nd European Lung Cancer Conference in Geneva, Switzerland.

4 May 2010

Role of pharmacists on primary care health teams to be discussed during Health Affairs press briefing

Smith will discuss the role of pharmacists on primary care health teams during a Health Affairs press briefing on Tuesday, May 4 at 11:30 a.m. ET. She will be joined by an interprofessional team of colleagues that includes Christine Cassell of the American Board of Internal Medicine, Joanne Pohl of the University of Michigan School of Nursing and Bill Leinweber from the American Academy of Physician Assistants.

4 May 2010

Study examines sleep issues in 2,800 people 100 years of age and older

A study in the May 1 issue of the journal SLEEP is the first to examine sleep issues in a large sample of exceptionally old adults, including nearly 2,800 people who were 100 years of age and older.

4 May 2010

Medical News

Amorfix Life Sciences detects AD-associated aggregated Beta-amyloid in blood plasma

Mylan Pharmaceuticals receives FDA approval for Bupropion HCl ER Tablets

Chances of surviving lung cancer much lower in England than in Norway or Sweden: Scientists

Henry Schein's net sales for first-quarter 2010 increase 18.5% to $1.8 billion

Tenet Healthcare reports adjusted EBITDA of $298 million for first-quarter 2010

GTx reports net income of $44.3M for first-quarter 2010 compared with net loss of $11.3M in 2009

First Edition: May 4, 2010

Celsion reports $4.6 million net loss from operations for first-quarter 2010

Positive results from Phase 2 clinical trial of TAKSTA in patients with ABSSSI

Personalized vaccine processed using tumor tissue promising for brain tumor treatment

New study finds stereotypies in more than 60% of orphaned or abandoned children

Pay-for-performance programs could end up widening medical disparities: RAND study

Cardiovascular specialists demonstrate effectiveness of using stents to repair aortas

Phase 2 clinical trial data of voreloxin to be presented at 2010 ASCO Annual Meeting: MicroStockProfit.com

Karolinska Institutet researchers discover new control mechanism in immune system

MicroStockProfit.com releases Hansen Medical investment report

Pilot pneumonia-prevention program reduces postoperative pneumonia in hospital surgical ward: Research

Approval of personalized therapy for lung cancer in Europe will change way of treatment

Role of pharmacists on primary care health teams to be discussed during Health Affairs press briefing

Study examines sleep issues in 2,800 people 100 years of age and older

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News